Published on 4 May 2024 on Simply Wall St. via Yahoo Finance
Bio-Techne Corporation (NASDAQ:TECH) defied analyst predictions to release its quarterly results, which were ahead of market expectations. The company beat expectations with revenues of US$303m arriving 3.6% ahead of forecasts. Statutory earnings per share (EPS) were US$0.31, 7.6% ahead of estimates. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
View our latest analysis for Bio-Techne
earnings-and-revenue-growth